Funding obtained under the CPP2024 Public-Private Partnership Projects call for the development of the TB-OMICS project, “Innovative software for tuberculosis diagnosis based on specific urinary biomarkers” (CPP2024-011551), aimed at developing and validating an innovative diagnostic solution for tuberculosis (TB). The project is based on the identification of specific metabolomic biomarkers in urine samples using low-field Nuclear Magnetic Resonance (NMR) technology combined with advanced computational analysis and artificial intelligence tools.
